severe rheumatoid arthritis or osteoarthritis, depression, and a history of cocaine, heroin
and marijuana use. The health care provider practitioner prescribed oxycodone 10 mg,
gabapentin 300 mg, and Etodolac* ER 400 mg.

66. In May 2012, Respondent began treating Patient 5 for left shoulder pain
and knee pain, and his internal medicine conditions, prescribing both oxycodone 10 mg
prn #90 and Percocet 10 mg tid, which he later discontinued.

67. On June 1, 2012, an x-ray of Patient 5’s shoulder showed “mild to
moderate osteoarthritis of the right acromioclavicular joint ... and right glenohumeral
joint.”

68. In October and November 2012, Patient 5’s toxicology screens were
negative for prescribed oxycodone. Respondent did not order another urine toxicology
screen until April 2013, which was positive for prescribed oxycodone.

69. In June 2014, Respondent increased oxycodone 10 mg to qid.

70. In October 2014, Patient 5’s toxicology screen was positive for marijuana.

71. — In May 2015, Respondent increased oxycodone to 30 mg tid.

72. Through March 2016, Respondent has maintained Patient 5 on
oxycodone 30 tid.

73. | Respondent fails to meet standards for quality pain medicine in regard to
his care and treatment of Patient 5, for reasons including but not limited to that he:

a. Fails to follow-up with imaging studies (MRI) that he has ordered on April
1, 2015 and still did not have results by October 5, 2015;

b. Escalates Patient 5 to a high dose of oxycodone 30 mg tid;
Cc. Fails to order frequent urine drug screens, obtaining only 12 screens over

3 Etodolac is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Etodolac is used
to treat pain or inflammation caused by arthritis.

19
